Advertisement

Topics

Latest "Bacterial Efflux Pump Inhibitors Pipeline Insights 2017 Updated" News Stories

12:40 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "Bacterial Efflux Pump Inhibitors Pipeline Insights 2017 Updated" found in our extensive news archives from over 250 global news sources.

More Information about Bacterial Efflux Pump Inhibitors Pipeline Insights 2017 Updated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Bacterial Efflux Pump Inhibitors Pipeline Insights 2017 Updated for you to read. Along with our medical data and news we also list Bacterial Efflux Pump Inhibitors Pipeline Insights 2017 Updated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Bacterial Efflux Pump Inhibitors Pipeline Insights 2017 Updated Companies for you to search.

Showing "Bacterial Efflux Pump Inhibitors Pipeline Insights 2017 Updated" News Articles 1–25 of 28,000+

Thursday 21st February 2019

Plant Antifreeze Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Plant Antifreeze report provides an independent information about the Plant Antifreeze industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.The rep...


Anti-Bacterial Coating Depends on Shape-Changing Element

NewsA research team is another step closer to developing germ-proof surface coatings for environments such as hospitals, after an unexpected development in the lab.

Pharmacy & Healthcare Communications LLC Launches Total Pharmacy™

A unique platform to provide pharmacy professionals with the insight and resources to drive profitability while improving patient care Pharmacy & Healthcare Communications LLC, the publisher of Pharmacy Times® and Specialty Pharmacy Times®, today announces the launch of Total Pharmacy™, a full-service media platform designed to redefine the val...


Merck to Acquire Immune Design for $300M, Boosting Immunotherapy Vaccine Pipeline

Merck & Co. said today it has agreed to acquire Immune Design for approximately $300 million, in a deal designed to boost the buyer’s vaccine pipeline and tech capabilities through a company that eliminated 18% of its workforce and named a new lead candidate late last year after its previous lead failed a clinical trial. […] The post Merck to Acquire Immune Design for $300M, Boosting I...

Motif Bio seeks talks with US drugs regulator

Motif’s lead drug candidate is iclaprim, a next-generation antibiotic for which it was seeking US FDA approval for use in patients with acute bacterial skin and skin structure infections

Road Bitumen Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Road Bitumen report provides an independent information about the Road Bitumen industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.The report woul...

Hangzhou Sciwind Completes $29.5 A Round for NASH Treatments

Hangzhou Sciwind Biosciences completed a $29.5 million series A round, led by Legend Capital. Established in 2017, Sciwind is developing protein and peptide candidates for non-alcoholic steatohepatitis (NASH) and the diseases it causes, including diabetes, liver fibrosis and cirrhosis. The company expects it will submit INDs for two undisclosed compounds in 2019. Shiyu Capital and Kawin participat...

Organic Beverages Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Organic Beverages report provides an independent information about the Organic Beverages industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.The r...

Pregnancy Test Meters Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Pregnancy Test Meters report provides an independent information about the Pregnancy Test Meters industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent developme...

Stents Related Implants Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Stents Related Implants report provides an independent information about the Stents Related Implants industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent dev...

Carol J. Burt Joins IQVIA Board of Directors

IQVIA™ (NYSE:IQV) today announced the appointment of Carol J. Burt to its board of directors, effective today. A principal of private investment firm Burt-Hilliard Investments for more than a decade, Burt is a former executive officer of WellPoint, Inc. (now Anthem, Inc.), lastly as Senior Vice President, Corporate Finance and Development, and previ...

Polypropylene PP Filler Masterbatch Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Polypropylene PP Filler Masterbatch report provides an independent information about the Polypropylene PP Filler Masterbatch industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business o...

Rigid Polyurethane Foam RPUF Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Rigid Polyurethane Foam RPUF report provides an independent information about the Rigid Polyurethane Foam RPUF industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and re...

Citi Appointed as Depositary Bank for Stealth BioTherapeutics’ ADR Programme

Citi, acting through Citibank N.A., has been appointed by Stealth BioTherapeutics Corp. (“Stealth”) as depositary bank for its American Depositary Receipt (“ADR”) programme. Stealth’s ADRs trade on the Nasdaq Global Market under the symbol “MITO.” Each ADR represents 12 ordinary shares of Stealth. “We are pleased to have been selec...

The observation of Neptune’s smallest and most recently discovered moon, Hippocamp, is reported in a paper published in Nature. The paper details Hippocamp’s size and orbit pattern, and suggests insights into its formation. https://go.nature.com/2NiU

The observation of Neptune’s smallest and most recently discovered moon, Hippocamp, is reported in a paper published in Nature. The paper details Hippocamp’s size and orbit pattern, and suggests insights into its formation. https://go.nature.com/2NiUgjl  pic.twitter.com/NlAYKvYtP8

Relief of Heartburn in Patients With Erosive Esophagitis

Does a new potassium-competitive acid blocker, vonoprazan, provide more rapid relief of heartburn than standard treatment with a proton-pump inhibitor? Alimentary Pharmacology & Therapeutics

Concert Pharmaceuticals to Report Full Year 2018 Results on February 28, 2019

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the year ended December 31, 2018, on Thursday, February 28, 2019, before the U.S. financial markets open. The Company will host a conference call and webcast at 8:30 a.m. ET to discuss 2018 financial results and provide a business update. Indiv...

Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2018 Financial Results Conference Call

Spectrum Pharmaceuticals (NasdaqGS: SPPI), announced today it will host a conference call with management to discuss the fourth quarter and full year 2018 financial results, provide an update on the company's business, and discuss expectations for the future on Thursday, February 28, 2019 at 4:30 p.m. Eastern/1:30 p.m. Pacific. Conference Call ...

ArQule to Present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Brian Schwartz, M.D., Chief Medical Officer and Head of Research and Development, of ArQule will present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019, at 11:30 a.m. ET at the Lotte New York Palace in New York City. The...

ArQule to Report Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019

ArQule, Inc. (Nasdaq: ARQL) today announced it will report financial results for the fourth quarter and full year of 2018 before the market opens on Thursday, March 7, 2019. The Company will hold a conference call and webcast on the same day at 9:00 a.m. ET to discuss these results and provide a general business update. The live webcast can be acc...

Exicure to Present at the 12th Annual European Life Sciences CEO Forum

Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced today that its CEO, Dr. David Giljohann, will present a corporate update at the 12th Annual European Life Sciences CEO Forum being held February 25-26, 2019 at the Hilton Zurich Airport Hotel in Zurich, Swi...

CHA Health Systems Subsidiary to Form the Largest Healthcare Network to Provide Premium Comprehensive Suite of Medical Services

CHS increased the share of SMG to approximately 24% to form the largest healthcare network in the Asia-Pacific region to develop a world-class oncology program, wellness center, and women’s health center CHA Health Systems (CHS), a global leader in bio-technology and

Verastem Oncology to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the Company will present at the 8th Annual SVB Leerink Global Healthcare Conference on Friday, March 1, 2019 at 10:30 a.m. EST in New York, NY. A l...

Teleflex Reports Fourth Quarter and Full Year 2018 Results; Provides 2019 Guidance

Fourth Quarter 2018 Revenues of $641.6 million, up 7.8% Versus Prior Year Period; up 9.4% on a Constant Currency Basis Fourth Quarter 2018 GAAP Diluted EPS from Continuing Operations of $1.87, up 303.3% Versus the Prior Year Period Fourth Quarter 2018 Adjusted Diluted EPS from Continuing Operations of $2.77, up 13.5% Versus Prior Year Per...

Morphic Therapeutic Enters Into Integrin Research and Development Collaboration with Janssen

Deal extends reach of Morphic discovery across all known human integrins Therapeutic potential of Morphic pipeline expanded by inclusion of both integrin inhibitor and activator research Collaboration facilitated by Johnson & Johnson Innovation, Boston Morphic Therapeutic (Morphic), a biotechnology ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks